NK cells can identify tumor cells via unique mechanisms that depend on a set of stimulatory and inhibitory receptors, such the NKp30, NKp46, NKG2D, and NKG2A, and these receptors, acting as switches, determine whether NK cells are activated to kill target cells. The gene discussed is NCR1; the disease is neoplasm.